Skip to main content

MoneyWorks4Me

The Sales for the quarter ended September 2026 of Rs. 8545.00 million declined by -32.41% from Rs. 12643.00 millions.Net profit of the cmpany stood at Rs. 1432.00 millions for the quarter ended September 2026 a decline of -71.41% from Rs. 5009.00 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 2566.00 millions from 6458.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 8545.00 12643.00 -32.41 14511.00 24570.00 -40.94 35946.00 40945.00 -12.21
Other Income 403.00 933.00 -56.81 886.00 1529.00 -42.05 2811.00 3213.00 -12.51
PBIDT 2566.00 6458.00 -60.27 4109.00 12451.00 -67.00 15860.00 24656.00 -35.67
Interest 156.00 117.00 33.33 252.00 143.00 76.22 323.00 196.00 64.80
PBDT 2410.00 6341.00 -61.99 3857.00 12308.00 -68.66 15537.00 24460.00 -36.48
Depreciation 440.00 481.00 -8.52 867.00 1019.00 -14.92 1896.00 2200.00 -13.82
PBT 1970.00 5860.00 -66.38 2990.00 11289.00 -73.51 13641.00 22260.00 -38.72
TAX 538.00 851.00 -36.78 812.00 1639.00 -50.46 826.00 3756.00 -78.01
Deferred Tax 314.00 -455.00 -169.01 478.00 -727.00 -165.75 -1858.00 -319.00 482.45
PAT 1432.00 5009.00 -71.41 2178.00 9650.00 -77.43 12815.00 18504.00 -30.74
Equity 358.00 358.00 0.00 358.00 358.00 0.00 358.00 358.00 0.00
PBIDTM(%) 30.03 51.08 -41.21 28.32 50.68 -44.12 44.12 60.22 -26.73
Peers
Company Name CMP
Sun Pharma. Inds. 1870.30
Dr. Reddys Labs. 1383.30
Cipla 1389.95
Lupin 1951.80
Zydus Lifesciences 1202.70
View more..